Cargando…
The Targeted Therapies Era Beyond the Surgical Point of View: What Spine Surgeons Should Know Before Approaching Spinal Metastases
In the last few years, the treatment of spinal metastases has significantly changed. This is due to the advancements in surgical technique, radiotherapy, and chemotherapy which have enriched the multidisciplinary management. Above all, the field of molecular biology of tumors is in continuous and pr...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728684/ https://www.ncbi.nlm.nih.gov/pubmed/31865766 http://dx.doi.org/10.1177/1073274819870549 |
_version_ | 1783449460588675072 |
---|---|
author | Cofano, Fabio Monticelli, Matteo Ajello, Marco Zenga, Francesco Marengo, Nicola Di Perna, Giuseppe Altieri, Roberto Cassoni, Paola Bertero, Luca Melcarne, Antonio Tartara, Fulvio Ducati, Alessandro Garbossa, Diego |
author_facet | Cofano, Fabio Monticelli, Matteo Ajello, Marco Zenga, Francesco Marengo, Nicola Di Perna, Giuseppe Altieri, Roberto Cassoni, Paola Bertero, Luca Melcarne, Antonio Tartara, Fulvio Ducati, Alessandro Garbossa, Diego |
author_sort | Cofano, Fabio |
collection | PubMed |
description | In the last few years, the treatment of spinal metastases has significantly changed. This is due to the advancements in surgical technique, radiotherapy, and chemotherapy which have enriched the multidisciplinary management. Above all, the field of molecular biology of tumors is in continuous and prosperous evolution. In this review, the molecular markers and new approaches that have radically modified the chemotherapeutic strategy of the most common metastatic neoplasms will be examined together with clinical and surgical implications. The experience and skills of several different medical professionals are mandatory: an interdisciplinary oncology team represents the winning strategy in the treatment of patients with spinal metastases |
format | Online Article Text |
id | pubmed-6728684 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-67286842019-09-13 The Targeted Therapies Era Beyond the Surgical Point of View: What Spine Surgeons Should Know Before Approaching Spinal Metastases Cofano, Fabio Monticelli, Matteo Ajello, Marco Zenga, Francesco Marengo, Nicola Di Perna, Giuseppe Altieri, Roberto Cassoni, Paola Bertero, Luca Melcarne, Antonio Tartara, Fulvio Ducati, Alessandro Garbossa, Diego Cancer Control Review In the last few years, the treatment of spinal metastases has significantly changed. This is due to the advancements in surgical technique, radiotherapy, and chemotherapy which have enriched the multidisciplinary management. Above all, the field of molecular biology of tumors is in continuous and prosperous evolution. In this review, the molecular markers and new approaches that have radically modified the chemotherapeutic strategy of the most common metastatic neoplasms will be examined together with clinical and surgical implications. The experience and skills of several different medical professionals are mandatory: an interdisciplinary oncology team represents the winning strategy in the treatment of patients with spinal metastases SAGE Publications 2019-09-04 /pmc/articles/PMC6728684/ /pubmed/31865766 http://dx.doi.org/10.1177/1073274819870549 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Review Cofano, Fabio Monticelli, Matteo Ajello, Marco Zenga, Francesco Marengo, Nicola Di Perna, Giuseppe Altieri, Roberto Cassoni, Paola Bertero, Luca Melcarne, Antonio Tartara, Fulvio Ducati, Alessandro Garbossa, Diego The Targeted Therapies Era Beyond the Surgical Point of View: What Spine Surgeons Should Know Before Approaching Spinal Metastases |
title | The Targeted Therapies Era Beyond the Surgical Point of View: What
Spine Surgeons Should Know Before Approaching Spinal Metastases |
title_full | The Targeted Therapies Era Beyond the Surgical Point of View: What
Spine Surgeons Should Know Before Approaching Spinal Metastases |
title_fullStr | The Targeted Therapies Era Beyond the Surgical Point of View: What
Spine Surgeons Should Know Before Approaching Spinal Metastases |
title_full_unstemmed | The Targeted Therapies Era Beyond the Surgical Point of View: What
Spine Surgeons Should Know Before Approaching Spinal Metastases |
title_short | The Targeted Therapies Era Beyond the Surgical Point of View: What
Spine Surgeons Should Know Before Approaching Spinal Metastases |
title_sort | targeted therapies era beyond the surgical point of view: what
spine surgeons should know before approaching spinal metastases |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728684/ https://www.ncbi.nlm.nih.gov/pubmed/31865766 http://dx.doi.org/10.1177/1073274819870549 |
work_keys_str_mv | AT cofanofabio thetargetedtherapieserabeyondthesurgicalpointofviewwhatspinesurgeonsshouldknowbeforeapproachingspinalmetastases AT monticellimatteo thetargetedtherapieserabeyondthesurgicalpointofviewwhatspinesurgeonsshouldknowbeforeapproachingspinalmetastases AT ajellomarco thetargetedtherapieserabeyondthesurgicalpointofviewwhatspinesurgeonsshouldknowbeforeapproachingspinalmetastases AT zengafrancesco thetargetedtherapieserabeyondthesurgicalpointofviewwhatspinesurgeonsshouldknowbeforeapproachingspinalmetastases AT marengonicola thetargetedtherapieserabeyondthesurgicalpointofviewwhatspinesurgeonsshouldknowbeforeapproachingspinalmetastases AT dipernagiuseppe thetargetedtherapieserabeyondthesurgicalpointofviewwhatspinesurgeonsshouldknowbeforeapproachingspinalmetastases AT altieriroberto thetargetedtherapieserabeyondthesurgicalpointofviewwhatspinesurgeonsshouldknowbeforeapproachingspinalmetastases AT cassonipaola thetargetedtherapieserabeyondthesurgicalpointofviewwhatspinesurgeonsshouldknowbeforeapproachingspinalmetastases AT berteroluca thetargetedtherapieserabeyondthesurgicalpointofviewwhatspinesurgeonsshouldknowbeforeapproachingspinalmetastases AT melcarneantonio thetargetedtherapieserabeyondthesurgicalpointofviewwhatspinesurgeonsshouldknowbeforeapproachingspinalmetastases AT tartarafulvio thetargetedtherapieserabeyondthesurgicalpointofviewwhatspinesurgeonsshouldknowbeforeapproachingspinalmetastases AT ducatialessandro thetargetedtherapieserabeyondthesurgicalpointofviewwhatspinesurgeonsshouldknowbeforeapproachingspinalmetastases AT garbossadiego thetargetedtherapieserabeyondthesurgicalpointofviewwhatspinesurgeonsshouldknowbeforeapproachingspinalmetastases AT cofanofabio targetedtherapieserabeyondthesurgicalpointofviewwhatspinesurgeonsshouldknowbeforeapproachingspinalmetastases AT monticellimatteo targetedtherapieserabeyondthesurgicalpointofviewwhatspinesurgeonsshouldknowbeforeapproachingspinalmetastases AT ajellomarco targetedtherapieserabeyondthesurgicalpointofviewwhatspinesurgeonsshouldknowbeforeapproachingspinalmetastases AT zengafrancesco targetedtherapieserabeyondthesurgicalpointofviewwhatspinesurgeonsshouldknowbeforeapproachingspinalmetastases AT marengonicola targetedtherapieserabeyondthesurgicalpointofviewwhatspinesurgeonsshouldknowbeforeapproachingspinalmetastases AT dipernagiuseppe targetedtherapieserabeyondthesurgicalpointofviewwhatspinesurgeonsshouldknowbeforeapproachingspinalmetastases AT altieriroberto targetedtherapieserabeyondthesurgicalpointofviewwhatspinesurgeonsshouldknowbeforeapproachingspinalmetastases AT cassonipaola targetedtherapieserabeyondthesurgicalpointofviewwhatspinesurgeonsshouldknowbeforeapproachingspinalmetastases AT berteroluca targetedtherapieserabeyondthesurgicalpointofviewwhatspinesurgeonsshouldknowbeforeapproachingspinalmetastases AT melcarneantonio targetedtherapieserabeyondthesurgicalpointofviewwhatspinesurgeonsshouldknowbeforeapproachingspinalmetastases AT tartarafulvio targetedtherapieserabeyondthesurgicalpointofviewwhatspinesurgeonsshouldknowbeforeapproachingspinalmetastases AT ducatialessandro targetedtherapieserabeyondthesurgicalpointofviewwhatspinesurgeonsshouldknowbeforeapproachingspinalmetastases AT garbossadiego targetedtherapieserabeyondthesurgicalpointofviewwhatspinesurgeonsshouldknowbeforeapproachingspinalmetastases |